{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:33:13Z","timestamp":1792855993391,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jchf.2026.103153","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:00:32Z","timestamp":1780430432000},"page":"103153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Screening and Treatment Using a Risk-Based Approach With NT-proBNP Guidance in Diabetes Mellitus"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6292-7464","authenticated-orcid":false,"given":"Vinayak","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kershaw V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude Moutchia","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DuWayne","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Bayes-Genis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambarish","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2026.103153_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2026.103153_bib2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diacare.27.3.699","article-title":"Heart failure prevalence, incidence, and mortality in the elderly with diabetes","volume":"27","author":"Bertoni","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2026.103153_bib3","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103153_bib4","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/ejhf.2723","article-title":"Optimal cardiometabolic health and risk of heart failure in type 2 diabetes: an analysis from the Look AHEAD trial","volume":"24","author":"Patel","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103153_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.103153_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jchf.2026.103153_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.jchf.2026.103153_bib8","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103153_bib9","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.2337\/dc24-S010","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2026.103153_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6139","article-title":"Association of race\/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US","volume":"4","author":"Eberly","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jchf.2026.103153_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2024-004431","article-title":"Recent trends in GLP-1 RA and SGLT2i use among people with type 2 diabetes and atherosclerotic cardiovascular disease in the USA","volume":"12","author":"King","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jchf.2026.103153_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100624","article-title":"Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015-2020","volume":"17","author":"Jacobs","year":"2024","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jchf.2026.103153_bib13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc21-1815","article-title":"Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the Department of Veterans Affairs","volume":"45","author":"Mahtta","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2026.103153_bib14","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.2337\/dc19-0587","article-title":"Machine learning to predict the risk of incident heart failure hospitalization among patients with diabetes: the WATCH-DM risk score","volume":"42","author":"Segar","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2026.103153_bib15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.119.042685","article-title":"Heart failure risk stratification and efficacy of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus","volume":"140","author":"Berg","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103153_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.123.067530","article-title":"Optimal screening for predicting and preventing the risk of heart failure among adults with diabetes without atherosclerotic cardiovascular disease: a pooled cohort analysis","volume":"149","author":"Patel","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103153_bib17","doi-asserted-by":"crossref","DOI":"10.2337\/dc25-1260","article-title":"Screening natriuretic peptide levels predicts heart failure and death in individuals with type 1 and type 2 diabetes without known heart failure","author":"Pop-Busui","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2026.103153_bib18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jchf.2023.01.012","article-title":"Natriuretic peptide-based screening for pre-heart failure in patients with type 2 diabetes across the United States","volume":"11","author":"Cunningham","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103153_bib19","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.jacc.2024.08.068","article-title":"A guide to implementation science for Phase 3 clinical trialists: designing trials for evidence uptake","volume":"84","author":"Van Spall","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103153_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024094","article-title":"Validation of the WATCH-DM and TRS-HF(DM) risk scores to predict the risk of incident hospitalization for heart failure among adults with type 2 diabetes: a multicohort analysis","volume":"11","author":"Segar","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2026.103153_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial","volume":"310","author":"Ledwidge","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2026.103153_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jacc.2013.05.069","article-title":"PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial","volume":"62","author":"Huelsmann","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103153_bib23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/archinternmed.2009.44","article-title":"Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial","volume":"169","author":"Bertoni","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jchf.2026.103153_bib24","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2023.2854","article-title":"Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes: a randomized clinical trial","volume":"329","author":"Pagidipati","year":"2023","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.jchf.2026.103153_bib25","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/CIRCULATIONAHA.124.069494","article-title":"Randomized evaluation of a remote management program to improve guideline-directed medical therapy: the Diabetes Remote Intervention to Improve Use of Evidence-based Medications (DRIVE) trial","volume":"149","author":"Blood","year":"2024","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jchf.2026.103153_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102755","article-title":"In-hospital virtual consultation to implement guideline-directed medical therapy for cardiovascular-kidney-metabolic disease: the IMPLEMENT-CRM randomized trial","volume":"14","author":"Shah","year":"2026","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103153_bib27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamacardio.2025.0871","article-title":"Leveraging preexisting cardiovascular data to improve the detection and treatment of hypertension: the NOTIFY-LVH randomized clinical trial","volume":"10","author":"Berman","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.jchf.2026.103153_bib28","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/19322968241264747","article-title":"Electronic health record alert with heart failure risk and sodium glucose cotransporter 2 inhibitor prescriptions in diabetes: a randomized clinical trial","volume":"19","author":"Segar","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jchf.2026.103153_bib29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamacardio.2022.2496","article-title":"Alerting clinicians to 1-year mortality risk in patients hospitalized with heart failure: the REVEAL-HF randomized clinical trial","volume":"7","author":"Ahmad","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.103153_bib30","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.jacc.2022.03.338","article-title":"Electronic alerts to improve heart failure therapy in outpatient practice: a cluster randomized trial","volume":"79","author":"Ghazi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103153_bib31","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jacc.2023.02.005","article-title":"Cluster-randomized trial comparing ambulatory decision support tools to improve heart failure care","volume":"81","author":"Mukhopadhyay","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103153_bib32","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.jacc.2023.02.029","article-title":"Virtual care team guided management of patients with heart failure during hospitalization","volume":"81","author":"Bhatt","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103153_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.120.051863","article-title":"An electronically delivered patient-activation tool for intensification of medications for chronic heart failure with reduced ejection fraction: the EPIC-HF Trial","volume":"143","author":"Allen","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103153_bib34","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(25)01393-5","article-title":"Prioritising the primary prevention of heart failure","volume":"406","author":"Khan","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2026.103153_bib35","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1161\/CIR.0000000000001307","article-title":"Risk-based primary prevention of heart failure: a scientific statement from the American Heart Association","volume":"151","author":"Khan","year":"2025","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.jchf.2026.103153_bib36","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2025.05.007","volume":"86","author":"Jones","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103153_bib37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jacc.2025.06.041","article-title":"Comparison of fixed vs age-adjusted NT-proBNP cutoffs to define pre-heart failure","volume":"86","author":"Cai","year":"2025","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926002532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926002532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:17:50Z","timestamp":1791256670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177926002532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2213177926002532"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103153","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening and Treatment Using a Risk-Based Approach With NT-proBNP Guidance in Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}],"article-number":"103153"}}